期刊文献+

强化饮食干预对代谢综合征患者代谢指标的影响 被引量:7

ALL METABOLISM INDEX OF PATIENT WITH METABOLIC SYNDROME UNDER THE INTERVENTION OF STRENGTHEN DIET
下载PDF
导出
摘要 目的探讨强化饮食干预对代谢综合征患者人体学指标与生化指标的影响。方法将200例代谢综合征病人随机分为2组,干预组、对照组各100例,干预组采用强化饮食干预3个月,随访3个月。结果强化饮食干预组患者体重、血压与糖代谢显著低于对照组和干预前,甘油三酯和高密度脂蛋白胆固醇无明显变化。结论强化饮食干预能改善代谢综合征患者的肥胖、血压、糖类代谢及胆固醇代谢,但对改善甘油三酯代谢效果不明显。 Objective To strengthen the diet intervention on human patients with metabolic syndrome and impact the biochemical indicators. Method 200 patients with metabolic syndrome were randomly divided into two groups, the intervention group and the control group with 100 cases each, the intervention group used strengthened dietary intervention for three months and follow - up three months. Result Strengthening the diet intervention, this group with obesity, blood pressure and glucose metabolism was significandy lower than the control group but tfiglyceride and high- density lipoprotein cholesterol without significant changes. Conclusion Strengthening the diet intervention can improve the obese patients with metabolic syndrome, blood pressure, cholesterol and carbohydrate metabolism, but not obvious effect of improving triglyceride metabolism.
出处 《现代医院》 2008年第2期8-9,共2页 Modern Hospitals
基金 深圳市科技计划医疗卫生类项目(项目编号200703070)
关键词 强化饮食干预 代谢综合征 护理研究 Strengthen diet intervention, Metabolic syndrome, Research of nursing
  • 相关文献

参考文献6

二级参考文献33

  • 1Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998,15 : 539-553.
  • 2Sheldon GS. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection,evaluation, and treatment of high blood cholesterol in adults (adult treatment ponel Ⅲ). JAMA,2001,19:2486-2497.
  • 3John WB, Vito MC, Albert AC, et al. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med, 1997, 157 :2413-2446.
  • 4Scott MG, Ivor JB, Gregory LB, et al. Diabetes and cardiovascular disease, a statemant for healthcare professionals the American Heart Association. Circulation, 1999,100:1134-1146.
  • 5Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002,287: 356-359.
  • 6Basu A, Basu R, Shah P, et al. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab, 2001, 280: E1000-E1006.
  • 7Solymossa BC, Bourassaa MG, Lespreancea J, et al. Incidence and clinical characteristics of metabolic syndrome in patients with coronary disease. Coronary Artery Disease, 2003, 14(3): 207-212 .
  • 8Lakka HM,Laaksonen DE,Lakka TA,et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288: 2709-2716.
  • 9Tuomilehto J,Lindstrom J,Eriksson FG,et al.Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.N Engl J Med,2001,344:1343-1350.
  • 10Knowler WC,Barrett-Connor E,Fowler SE,et al.Reduction in the incidence of type 2 diabetes with lifestyle intervention or merformin.N Engl J Med, 2002,346:393-403 .

共引文献93

同被引文献126

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部